US Stock MarketDetailed Quotes

CGTX Cognition Therapeutics

Watchlist
  • 0.630
  • -0.004-0.62%
Close Dec 20 16:00 ET
  • 0.615
  • -0.015-2.38%
Post 19:59 ET
26.18MMarket Cap-0.66P/E (TTM)

Cognition Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-33.24%22.01M
-23.28%28.53M
-10.66%34.67M
-28.01%29.92M
-28.01%29.92M
-29.27%32.97M
-18.75%37.19M
-24.65%38.81M
-24.05%41.56M
-24.05%41.56M
-Cash and cash equivalents
-33.24%22.01M
-23.28%28.53M
-10.66%34.67M
-28.01%29.92M
-28.01%29.92M
-29.27%32.97M
-18.75%37.19M
-24.65%38.81M
-24.05%41.56M
-24.05%41.56M
Receivables
105.68%3.37M
29.50%3.1M
-46.49%861K
-65.11%1.28M
-65.11%1.28M
-35.21%1.64M
-27.37%2.39M
-42.41%1.61M
62.05%3.67M
62.05%3.67M
-Other receivables
105.68%3.37M
29.50%3.1M
-46.49%861K
-65.11%1.28M
-65.11%1.28M
-35.21%1.64M
-27.37%2.39M
-42.41%1.61M
62.05%3.67M
62.05%3.67M
Other current assets
1.19%1.45M
-2.54%1.92M
2.27%2.44M
25.11%3.02M
25.11%3.02M
--1.43M
--1.97M
--2.38M
20.35%2.41M
20.35%2.41M
Total current assets
-25.55%26.83M
-19.26%33.55M
-11.29%37.97M
-28.18%34.22M
-28.18%34.22M
-29.24%36.04M
-18.11%41.55M
-24.17%42.8M
-19.23%47.65M
-19.23%47.65M
Non current assets
Net PPE
-23.34%749K
-16.77%819K
-14.02%883K
-10.04%941K
-10.04%941K
4.27%977K
25.51%984K
22.41%1.03M
621.38%1.05M
621.38%1.05M
-Gross PPE
-23.34%749K
-16.77%819K
-14.02%883K
-0.45%1.99M
-0.45%1.99M
4.27%977K
25.51%984K
22.41%1.03M
96.95%2M
96.95%2M
-Accumulated depreciation
----
----
----
-10.07%-1.05M
-10.07%-1.05M
----
----
----
-9.54%-953K
-9.54%-953K
Other non current assets
----
----
----
----
----
3.97%1.76M
10.89%1.43M
29.50%1.84M
--1.73M
--1.73M
Total non current assets
-72.58%749K
-66.00%819K
-69.15%883K
-66.13%941K
-66.13%941K
4.08%2.73M
16.43%2.41M
26.86%2.86M
1,815.86%2.78M
1,815.86%2.78M
Total assets
-28.87%27.58M
-21.82%34.37M
-14.92%38.85M
-30.27%35.16M
-30.27%35.16M
-27.61%38.77M
-16.76%43.96M
-22.20%45.66M
-14.73%50.43M
-14.73%50.43M
Liabilities
Current liabilities
Payables
-33.72%1.9M
-25.27%3.03M
-15.42%2.64M
14.89%3.7M
14.89%3.7M
-64.65%2.86M
22.88%4.06M
-24.31%3.12M
-22.84%3.22M
-22.84%3.22M
-accounts payable
-33.72%1.9M
-25.27%3.03M
-15.42%2.64M
14.89%3.7M
14.89%3.7M
-64.65%2.86M
22.88%4.06M
-21.94%3.12M
-22.84%3.22M
-22.84%3.22M
Current accrued expenses
138.20%8.03M
215.48%4.97M
152.60%4.13M
136.11%2.89M
136.11%2.89M
228.04%3.37M
71.49%1.58M
1,359.82%1.64M
162.66%1.22M
162.66%1.22M
Current debt and capital lease obligation
9.30%188K
-3.66%369K
-6.51%546K
-8.30%718K
-8.30%718K
50.88%172K
-31.97%383K
-38.46%584K
--783K
--783K
-Current debt
----
-14.75%185K
-14.29%366K
-14.20%544K
-14.20%544K
--2K
-46.02%217K
-46.56%427K
--634K
--634K
-Current capital lease obligation
10.59%188K
10.84%184K
14.65%180K
16.78%174K
16.78%174K
49.12%170K
3.11%166K
4.67%157K
--149K
--149K
Current deferred liabilities
22.75%1.12M
37.59%1.45M
-3.77%1.58M
-0.06%1.7M
-0.06%1.7M
-43.16%910K
-17.76%1.06M
25.08%1.65M
126.03%1.7M
126.03%1.7M
Current liabilities
54.39%12.71M
37.98%10.92M
27.30%9.5M
30.46%10.17M
30.46%10.17M
-32.08%8.23M
16.08%7.91M
-2.35%7.47M
-0.88%7.8M
-0.88%7.8M
Non current liabilities
Long term debt and capital lease obligation
-30.62%392K
-27.63%440K
-25.04%488K
-25.18%520K
-25.18%520K
-6.30%565K
50.50%608K
45.96%651K
--695K
--695K
-Long term capital lease obligation
-30.62%392K
-27.63%440K
-25.04%488K
-25.18%520K
-25.18%520K
-6.30%565K
50.50%608K
45.96%651K
--695K
--695K
Non current deferred liabilities
----
----
----
--0
--0
-30.70%1.05M
-37.79%1.05M
-5.42%1.76M
--1.69M
--1.69M
Total non current liabilities
-75.76%392K
-73.49%440K
-79.79%488K
-78.16%520K
-78.16%520K
-23.76%1.62M
-20.76%1.66M
4.50%2.42M
--2.38M
--2.38M
Total liabilities
33.02%13.1M
18.65%11.36M
1.12%9.99M
5.04%10.69M
5.04%10.69M
-30.84%9.85M
7.42%9.57M
-0.76%9.88M
29.40%10.18M
29.40%10.18M
Shareholders'equity
Share capital
36.67%41K
33.33%40K
37.93%40K
10.34%32K
10.34%32K
25.00%30K
36.36%30K
31.82%29K
31.82%29K
31.82%29K
-common stock
36.67%41K
33.33%40K
37.93%40K
10.34%32K
10.34%32K
25.00%30K
36.36%30K
31.82%29K
31.82%29K
31.82%29K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-25.76%-167.32M
-24.61%-157.38M
-23.66%-150.34M
-22.35%-141.19M
-22.35%-141.19M
-20.71%-133.05M
-21.92%-126.3M
-24.25%-121.57M
-22.76%-115.4M
-22.76%-115.4M
Paid-in capital
12.10%181.76M
12.12%180.35M
13.74%179.16M
6.42%165.83M
6.42%165.83M
8.30%162.14M
8.93%160.85M
7.34%157.52M
7.13%155.82M
7.13%155.82M
Gains losses not affecting retained earnings
--0
--0
--0
2.01%-195K
2.01%-195K
2.49%-196K
2.00%-196K
1.02%-195K
-0.51%-199K
-0.51%-199K
Total stockholders'equity
-49.93%14.48M
-33.09%23.01M
-19.35%28.86M
-39.19%24.47M
-39.19%24.47M
-26.43%28.93M
-21.67%34.39M
-26.58%35.78M
-21.50%40.25M
-21.50%40.25M
Total equity
-49.93%14.48M
-33.09%23.01M
-19.35%28.86M
-39.19%24.47M
-39.19%24.47M
-26.43%28.93M
-21.67%34.39M
-26.58%35.78M
-21.50%40.25M
-21.50%40.25M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -33.24%22.01M-23.28%28.53M-10.66%34.67M-28.01%29.92M-28.01%29.92M-29.27%32.97M-18.75%37.19M-24.65%38.81M-24.05%41.56M-24.05%41.56M
-Cash and cash equivalents -33.24%22.01M-23.28%28.53M-10.66%34.67M-28.01%29.92M-28.01%29.92M-29.27%32.97M-18.75%37.19M-24.65%38.81M-24.05%41.56M-24.05%41.56M
Receivables 105.68%3.37M29.50%3.1M-46.49%861K-65.11%1.28M-65.11%1.28M-35.21%1.64M-27.37%2.39M-42.41%1.61M62.05%3.67M62.05%3.67M
-Other receivables 105.68%3.37M29.50%3.1M-46.49%861K-65.11%1.28M-65.11%1.28M-35.21%1.64M-27.37%2.39M-42.41%1.61M62.05%3.67M62.05%3.67M
Other current assets 1.19%1.45M-2.54%1.92M2.27%2.44M25.11%3.02M25.11%3.02M--1.43M--1.97M--2.38M20.35%2.41M20.35%2.41M
Total current assets -25.55%26.83M-19.26%33.55M-11.29%37.97M-28.18%34.22M-28.18%34.22M-29.24%36.04M-18.11%41.55M-24.17%42.8M-19.23%47.65M-19.23%47.65M
Non current assets
Net PPE -23.34%749K-16.77%819K-14.02%883K-10.04%941K-10.04%941K4.27%977K25.51%984K22.41%1.03M621.38%1.05M621.38%1.05M
-Gross PPE -23.34%749K-16.77%819K-14.02%883K-0.45%1.99M-0.45%1.99M4.27%977K25.51%984K22.41%1.03M96.95%2M96.95%2M
-Accumulated depreciation -------------10.07%-1.05M-10.07%-1.05M-------------9.54%-953K-9.54%-953K
Other non current assets --------------------3.97%1.76M10.89%1.43M29.50%1.84M--1.73M--1.73M
Total non current assets -72.58%749K-66.00%819K-69.15%883K-66.13%941K-66.13%941K4.08%2.73M16.43%2.41M26.86%2.86M1,815.86%2.78M1,815.86%2.78M
Total assets -28.87%27.58M-21.82%34.37M-14.92%38.85M-30.27%35.16M-30.27%35.16M-27.61%38.77M-16.76%43.96M-22.20%45.66M-14.73%50.43M-14.73%50.43M
Liabilities
Current liabilities
Payables -33.72%1.9M-25.27%3.03M-15.42%2.64M14.89%3.7M14.89%3.7M-64.65%2.86M22.88%4.06M-24.31%3.12M-22.84%3.22M-22.84%3.22M
-accounts payable -33.72%1.9M-25.27%3.03M-15.42%2.64M14.89%3.7M14.89%3.7M-64.65%2.86M22.88%4.06M-21.94%3.12M-22.84%3.22M-22.84%3.22M
Current accrued expenses 138.20%8.03M215.48%4.97M152.60%4.13M136.11%2.89M136.11%2.89M228.04%3.37M71.49%1.58M1,359.82%1.64M162.66%1.22M162.66%1.22M
Current debt and capital lease obligation 9.30%188K-3.66%369K-6.51%546K-8.30%718K-8.30%718K50.88%172K-31.97%383K-38.46%584K--783K--783K
-Current debt -----14.75%185K-14.29%366K-14.20%544K-14.20%544K--2K-46.02%217K-46.56%427K--634K--634K
-Current capital lease obligation 10.59%188K10.84%184K14.65%180K16.78%174K16.78%174K49.12%170K3.11%166K4.67%157K--149K--149K
Current deferred liabilities 22.75%1.12M37.59%1.45M-3.77%1.58M-0.06%1.7M-0.06%1.7M-43.16%910K-17.76%1.06M25.08%1.65M126.03%1.7M126.03%1.7M
Current liabilities 54.39%12.71M37.98%10.92M27.30%9.5M30.46%10.17M30.46%10.17M-32.08%8.23M16.08%7.91M-2.35%7.47M-0.88%7.8M-0.88%7.8M
Non current liabilities
Long term debt and capital lease obligation -30.62%392K-27.63%440K-25.04%488K-25.18%520K-25.18%520K-6.30%565K50.50%608K45.96%651K--695K--695K
-Long term capital lease obligation -30.62%392K-27.63%440K-25.04%488K-25.18%520K-25.18%520K-6.30%565K50.50%608K45.96%651K--695K--695K
Non current deferred liabilities --------------0--0-30.70%1.05M-37.79%1.05M-5.42%1.76M--1.69M--1.69M
Total non current liabilities -75.76%392K-73.49%440K-79.79%488K-78.16%520K-78.16%520K-23.76%1.62M-20.76%1.66M4.50%2.42M--2.38M--2.38M
Total liabilities 33.02%13.1M18.65%11.36M1.12%9.99M5.04%10.69M5.04%10.69M-30.84%9.85M7.42%9.57M-0.76%9.88M29.40%10.18M29.40%10.18M
Shareholders'equity
Share capital 36.67%41K33.33%40K37.93%40K10.34%32K10.34%32K25.00%30K36.36%30K31.82%29K31.82%29K31.82%29K
-common stock 36.67%41K33.33%40K37.93%40K10.34%32K10.34%32K25.00%30K36.36%30K31.82%29K31.82%29K31.82%29K
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -25.76%-167.32M-24.61%-157.38M-23.66%-150.34M-22.35%-141.19M-22.35%-141.19M-20.71%-133.05M-21.92%-126.3M-24.25%-121.57M-22.76%-115.4M-22.76%-115.4M
Paid-in capital 12.10%181.76M12.12%180.35M13.74%179.16M6.42%165.83M6.42%165.83M8.30%162.14M8.93%160.85M7.34%157.52M7.13%155.82M7.13%155.82M
Gains losses not affecting retained earnings --0--0--02.01%-195K2.01%-195K2.49%-196K2.00%-196K1.02%-195K-0.51%-199K-0.51%-199K
Total stockholders'equity -49.93%14.48M-33.09%23.01M-19.35%28.86M-39.19%24.47M-39.19%24.47M-26.43%28.93M-21.67%34.39M-26.58%35.78M-21.50%40.25M-21.50%40.25M
Total equity -49.93%14.48M-33.09%23.01M-19.35%28.86M-39.19%24.47M-39.19%24.47M-26.43%28.93M-21.67%34.39M-26.58%35.78M-21.50%40.25M-21.50%40.25M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
NVIDIA
NVDA
+3.08%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%

Unlock the Full List